Fiche publication
Date publication
octobre 2018
Journal
Biotechnology journal
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BOSCHI-MULLER Sandrine
,
Pr JOUZEAU Jean-Yves
Tous les auteurs :
Kriznik A, Yéléhé-Okouma M, Lec JC, Groshenry G, Le Cordier H, Charron C, Quinternet M, Mazon H, Talfournier F, Boschi-Muller S, Jouzeau JY, Reboul P
Lien Pubmed
Résumé
Purification of recombinant proteins remains a bottleneck for downstream processing. We engineered a new galectin 3 truncated form (CRD ), functionally and structurally characterized, with preserved solubility and lectinic activity. Taking advantage of these properties, we designed an expression vector (pCARGHO), suitable for CRD -tagged protein expression in prokaryotes. CRD binds to lactose-Sepharose with a high specificity and facilitates solubilization of fusion proteins. This tag is structurally stable and can be easily removed from fusion proteins using TEV protease. Furthermore, due to their basic isoelectric point (pI), CRD and TEV are efficiently eliminated using cationic exchange chromatography. When pI of the protein of interest and CRD were close, other chromatographic methods were successfully tested. Using CRD tag, we purified several proteins from prokaryote and eukaryote origin and demonstrated as examples, the preservation of both Escherichia coli Thioredoxin 1 and human CDC25B activities. Overall, yields of proteins obtained after tag removal were about 5 to 50 mg per litre of bacterial culture. Our purification method displays various advantages described herein that may greatly interest academic laboratories, biotechnology and pharmaceutical companies.
Mots clés
affinity chromatography, downstream processing, galectin-3-derived CRD-tag, protein purification based on new tag technology
Référence
Biotechnol J. 2018 Oct 8;:e1800214